Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis.

Acta biomaterialia - 15 Sept 2016

Zamani Maedeh, Prabhakaran Molamma P, Varshosaz Jaleh, Mhaisalkar Priyadarshini S, Ramakrishna Seeram

Abstract excerpt

UNLABELLED: Drug-eluting stents (DESs), have shown promising results in prevention of in-stent restenosis after percutaneous coronary intervention (PCI). The elevated level of leukotrienes (LTs) detected in injured arteries after PCI, together with the potential role of LTs in inflammatory cascades and structural alterations in arterial wall provides the rationale for development of therapeutic strategies for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetates
Share to Calorimetry, Differential Scanning

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Restenosis

Share to Coronary Vessels

Share to Cyclopropanes

Share to Lactic Acid

Share to Stents

Share to Sulfides

Source

Identifiers

PMID: 27397493
DOI: 10.1016/j.actbio.2016.07.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis.PMID 27397493Read ↗

A drug-free, engineered hybrid exosome platform alleviates atherosclerosis via inflammation modulation and phenotype remodeling.Semantic proximity Read ↗

Nanoparticle coatings for controlled release of quercetin from an angioplasty balloonSemantic proximity Read ↗

Nanoparticle-Mediated Cell Capture Enables Rapid Endothelialization of a Novel Bare Metal Stent.Semantic proximity Read ↗

Advances in Fabrication Technologies for Development of Next-generation Cardiovascular StentsSemantic proximity Read ↗

One Produces Multi: A Drug-free Cardiovascular Stent Functionalized with Tailored Collagen Supports in-situ Healing of Vascular TissuesSemantic proximity Read ↗

A tough endothelium-like dressing for vascular stentsSemantic proximity Read ↗

Coronary Drug-Coated Balloons as Brief-Contact Drug-Delivery Platforms: Engineering, Tissue Pharmacokinetics, and Angiographic/Imaging ResponseSemantic proximity Read ↗

Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses.Semantic proximity Read ↗

Nanoparticle design for drug delivery to atherosclerotic plaquesSemantic proximity Read ↗

Bioactive surfaces for improved coronary stent performanceSemantic proximity Read ↗

MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia.Semantic proximity Read ↗

Camouflaging Endovascular Stents With an Endothelial Coat Using CD31 Domain 1 Mimetic PeptidesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.